By Daniel R. Lucey MD, MPH, FIDSA The SARS-CoV-2 variants first described in Manaus, Brazil “P.1.” and in South Africa “B.1.351” share at least five mutations including the antibody-evading changes at amino acids 484 and 417 in the spike protein. Potential cross-protection against the P.1 variant by the new Moderna-NIH B1.351 variant vaccine has been […]More »
By Daniel R. Lucey MD, MPH, FIDSA Two manuscripts from Brazil, newly posted by accomplished researchers on preprint servers, report that the P.1 variant “associated with rapid transmission in Manaus” (by Faria N. et al.) and reported in the U.S. and 28 other nations, “may escape from neutralizing antibodies generated in response to polyclonal stimulation […]More »
In March NIH will start the first variant-specific COVID vaccine study: Will this B.1.351-variant vaccine also induce some immunity to the P.1 variant?
By Daniel R. Lucey MD, MPH, FIDSA On Friday (Feb. 26) National Institute of Allergy and Intections Diseases Director /NIH Dr. Anthony Fauci, announced plans to start vaccine studies for the first time using the variant B.1.351, now dominant in South Africa and present in the United States. It contains the E484K mutation and also […]More »
By Daniel R. Lucey MD, MPH, FIDSA On Wednesday (Feb. 24) Moderna announced a new vaccine strategy against the variant B.1.351 (501Y.V2) now predominant in several nations in southern Africa, and identified in more than 40 nations, as well as multiple U.S. states. Part of this strategy is the first-ever “multivalent” vaccine candidate that “combines […]More »
WHO posts global maps of three SARS-CoV-2 variants in 88, 37, and 17 nations: Juxtaposition with a vaccine in South Africa?
What We're Reading: How inequities driving COVID-19 in Black communities now drive inequities in COVID-19 access
First long-acting injectable treatment for HIV represents an exciting step forward, should be optimized with equity, investment
COVID-19: The vaccine is here! Now we need to get it out, and into arms
It’s a puzzle, it’s an algorithm, it’s deduplication
Live Blog Archive
- 48th Union World Conference on Lung Health
- 9th International AIDS Society Conference on HIV Science
- 2017 Conference on Retroviruses and Opportunistic Infections, Seattle
- 65th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta
- 47th Union World Conference on Lung Health, Liverpool, England
- IDWeek Meeting, New Orleans
- HIV Research for Prevention Conference, Chicago
- International AIDS Conference, Durban, South Africa
- United Nations High Level Meeting on HIV/AIDS, New York
- 23rd Conference on Retroviruses and Opportunistic Infections, Boston
- 46th Union World Conference on Lung Health, Capetown, South Africa
- IDWeek Meeting, San Diego
- International AIDS Conference, Vancouver, Canada
- 22nd Conference on Retroviruses and Opportunistic Infections, Seattle
- 45th Union World Conference on Lung Health, Barcelona, Spain
- HIV Research for Prevention Conference, Cape Town, South Africa
- IDWeek 2014, Philadelphia
- 20th International AIDS Conference, Melbourne, Australia
- 21st Conference on Retroviruses and Opportunistic Infections, Boston
- AIDS Vaccine Conference 2013, Barcelona
- IDWeek 2013, San Francisco
- 20th Conference on Retroviruses and Opportunistic Infections
- IDWeek 2012
- 19th Annual International AIDS Conference held in Washington, DC.
- 2nd International Treatment as Prevention Workshop, Vancouver
- The 19th annual Conference on Retroviruses and Opportunistic Infections, Seattle.
- The 60th Annual Meeting of the American Society of Tropical Medicine and Hygiene.
- The 42nd Union World Conference on Lung Health, Lille, France.
- The Infectious Diseases Society of America's 49th Annual Meeting.
- The 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Rome.
- Conference on Retroviruses and Opportunistic Infections, Boston.
- 41st Union World Conference on Lung Health, Berlin, Germany.
- IDSA Annual Meeting, Vancouver
- The 18th International AIDS Conference, Vienna.
- Center for Global Health Policy and GHC Briefing on HIV/TB Coinfection, Washington, DC
- Conference on Retroviruses and Opportunistic Infections, San Francisco
- Consortium of Universities for Global Health Annual Meeting, Washington D.C.
- 2009 International AIDS Conference, Cape Town
- Pacific Health Summit, Seattle, Washington.
- HIV/AIDS Implementers Conference, Windhoek, Namibia.
Click above for a video on our Congressional study tour to Africa, and click here to read more.
Steeped in inequities that include formidable barriers to basic health services for multitudes of its most vulnerable, marginalized and neglected people, the country leading global HIV […]
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
CDC urges physicians, parents to be on lookout for AFM, a polio-like illness seen predominately in children
With 2018 data showing highest incidence acute flaccid myelitis since monitoring began, officials say awareness, recognition of rare life threatening condition will be crucial to early […]
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]